2 most recent filings and news items mentioning EHC. Updated every 60 seconds.
Guidance|BuybackAug 5, 2026Neutral
Encompass Health reported robust Q2 2026 results and raised its full-year guidance for net operating revenue and adjusted earnings, alongside increasing its common stock repurchase authorization to $1 billion.
View filing at SEC.gov →
OfferingJun 1, 2026Neutral
Encompass Health Corporation established an indenture for 5.875% senior notes maturing in 2034 with ComputerShare as trustee. The debt offering provides capital for operations while subsidiary guarantors support the obligation.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.